Background. Peritoneal infection and poor ultrafiltration continue to be the major causes of treatment failure in CAPD. The combined effects of peritonitis and the continuous exposure to dialysis fluid remain the most likely candidates affecting the peritoneum in the long term. The purpose of this study was to observe the effects of peritonitis and dialysis on longitudinal peritoneal function. Methods. The peritoneal equilibration test (PET) was utilized to quantify longitudinal changes in lowmolecular-weight solute transfer (D/P creat ) and ultrafiltration (UF) in 233 patients treated with CAPD. Of these, 166 represented an unselected cohort (Group 1) studied prospectively from commencing treatment for up to 54 months, and 67 were selected patients (Group 2) with PET data available at commencement of the study, having been on dialysis for a minimum of 18 months. PETs were performed either 6-monthly or following peritonitis episodes. Results. Data on the short-term effect of peritonitis kinetics were pooled for groups 1 and 2. Single, isolated episodes (« = 86) had no significant effect on D/P creat or UF, whereas recurrences or clusters of infection (n = 70) caused increases in D/P creat and reductions in UF, the significance of which increased with the number of episodes. There were significant correlations between both changes in D/P crcat and UF with the cumulative dialysate leukocyte count, regardless of infecting organism, suggesting that intensity of peritoneal inflammation is also important. Those organisms associated with greater change in peritoneal kinetics, e.g. S. aureus, Pseudomonas, also had the highest neutrophil counts.
Introduction
Whilst in the short to medium term there is good evidence supporting the efficacy of CAPD as a treatment modality in comparison to haemodialysis [1, 2] , concerns remain with respect to the longer term. These may be reduced to two issues, the inability to deliver an adequate dialysis dose once residual renal function has gone [3] , and a progressive peritoneal damage resulting in a reduction of ultrafiltration capacity. Recurrent peritonitis and ultrafiltration failure continue to be the two most important causes of treatment drop-out, and as with dialysis dose, problems with poor ultrafiltration may only become manifest once there is no urine output. There is, however, evidence that the incidence of ultrafiltration failure truly increases with time spent on CAPD [4] , suggesting that structural and functional changes occur within the peritoneal membrane.
The principal candidates for the causes of these changes are the acute inflammatory damage associated with peritonitis and the continuous low-grade irritation of the membrane due to the bioincompatibility of Longitudinal peritoneal kinetics and peritonitis dialysate. Both retrospective and prospective studies have found high cumulative peritonitis rates to be a risk factor for ultrafiltration failure [5] [6] [7] , and acute peritoneal inflammation can cause morphological damage to the peritoneum [8, 9] . Low-grade activation of peritoneal mononuclear cells [10] [11] [12] , cytokine release [13, 14] , and mesothelial cell injury have also been demonstrated in the uninfected peritoneum, or in vitro following exposure to dialysate [15] , indicative of a mechanism which may cause progressive damage. The purpose of this study was to observe prospectively longitudinal changes in peritoneal kinetics, occurring over a period of 5 years, to determine the effects of dialysis and peritonitis on peritoneal function.
Subjects and methods

Patient populations
Two hundred and thirty-three patients were studied during the period January 1990 to October 1995. They comprised two groups, a cohort of 166 unselected patients commencing dialysis within this period (group 1), and a further 67 patients (group 2) who had been on dialysis a minimum of 18 months, who underwent episodes of peritonitis during the study period, in whom prior longitudinal peritoneal kinetic data was available. No patients were excluded from study on the basis of primary diagnosis, comorbidity or clinical outcome, and the median age was 56 years, (range 15-82).
Study design
Following entry to the study all patients underwent routine assessment of peritoneal kinetics (PET) every 6 months. Patients in group 1 had their first PET following the completion of training for CAPD, within 1 month of commencing treatment. In retrospect this was probably too early to provide a stable baseline for peritoneal function (see Discussion section). No PET was performed during or within a month of the commencement of peritonitis, and this sometimes caused postponement of routine testing by a few weeks. Episodes of peritonitis were carefully documented, including results of culture for micro-organisms, outcome, and the dialysate leukocyte counts on presentation (day 1) and from the overnight dwells on day 3 and day 12 of infection. Where possible the next PET was performed 30 days after the commencement of the peritonitis episode, although this was postponed if the patient had recurrent peritonitis or required removal of the peritoneal catheter. Under these circumstances the PET was performed either 30 days after the commencement of the recurrent episode, 30 days after commencement of the last episode in a cluster of peritonitis, or in those patients whose catheter was removed 14-21 days following reinsertion after having rested the peritoneum for 1 month on haemodialysis. Throughout the study glucose was the osmotic agent and lactate (40 mmol/1) the buffer present in the commercial dialysate solutions used. Patients were instructed only to utilize glucose concentrations of 2.27% or greater in response to poor ultrafiltration volumes, and not as a method of increasing dialysate volumes for the purpose of augmenting dialysis dose. A cross-sectional and longitudinal analysis of utilization of hypertonic dialysate solutions by our patients has indicated that this is appropriate for their peritoneal kinetics and residual urine 499 volume, with 15% of patients requiring three or more hypertonic exchanges per day (data in press (Clinical Nephrology)).
Peritoneal equilibration test
The peritoneal equilibration test was utilized to measure peritoneal kinetics [16] , and this was performed as described previously [17] . Briefly, a standard 4-h dwell period was used (first exchange of the day), using a 2.27% glucose concentration 2-litre volume exchange. The patient used their usual overnight dialysis regime, and both the overnight and test drainage volumes were measured. Net ultrafiltration (UF) was calculated as the difference between the 2 litres of instilled dialysate and the volume drained after the 4-h dwell. The dialysate to plasma ratio of creatinine at the completion of the 4-h dwell period, (D/P creat ), was used as the estimate of low-molecular-weight solute transfer. As glucose interferes with the assay for creatinine in a linear fashion, concentrations for both these solutes are measured at 4 h and the true value for creatinine obtained by subtracting the glucose concentration multiplied by a correction factor derived locally by our laboratory (0.47). Using this method the 4-h D/P creat is a highly reproducible measure of low-molecularweight solute transfer across a wide range of values (0.45-0.9), in the short term (3 months or less provided there has been to clinical event such as peritonitis or surgery), with a coefficient of variation of 3-5%. Normal ranges +95% CI for D/P crt . at 0.635 + 0.25 and net ultrafiltration 498 ml+ 409, their normal interrelationship (linear negative correlation, r=-0.59) and their values (D/P creat + SD, net ultrafiltration+ SD) in patients with type 1 (0.91+0.03, 64 ml± 114), type 2 (0.75 + 0.075, -93 ml+ 232) and mixed (0.76 + 0.04, 161ml + 118) ultrafiltration failure have been described previously in this journal [17] .
Definitions and treatment of peritonitis
Peritonitis was defined as a dialysate leukocyte count of 100 cells/10~6 1 or more, with or without accompanying clinical features such as abdominal pain, fever or a positive culture. All episodes were initially treated with intraperitoneal vancomycin and gentamicin in accordance with national guidelines throughout the study period, on an intention to treat basis, until microbial sensitivities became available, at which point appropriate changes were made [18] . Treatment was continued in each case for 10 days, and the dialysate leukocyte checked on day 12 to document resolution of peritoneal inflammation. An isolated episode was defined as an infection occurring in a peritoneum not infected in the previous 2 calendar months that resolved completely and did not form part of a cluster (vide infra) of infections. Multiple infections included recurrences, true (as judged by the same organism) or putative, defined as further 'culture negative' episodes occurring within 1 calendar month, or clusters of infections (3 or more occurring within a 6-month period) which technically fell outside the definition of recurrence but could not be considered as isolated. The indications for Tenckhoff catheter removal, which were consistent throughout the study period, were as follows. In patients having three infections forming a cluster. Audit of this protocol was performed during the study period, which indicated that it was closely adhered to. However, on retrospective analysis it was apparent that on 13 of 41 occasions clusters involved four peritoneal infections, due to deferral of Tenckhoff removal, either because of very strong patient preference or exceptional clinical circumstances. All patients were treated with appropriate intraperitoneal antibiotics until the point of catheter removal at which point they had systemic antibiotic for 5 days. Patients with fungal peritonitis were given systemic fluconazole. There was a steady introduction of disconnect systems such that these represented 95% of those in use towards the end of the study period. This was associated with a reduction in total peritonitis rates from 1 in 9 to 1 in 19 patient months over the study period.
Analytical methods
Plasma and dialysate concentrations of creatinine and glucose were determined on an automated discrete random access analyser (DAX 72, Bayer Instruments, Basingstoke, UK). The glucose within the dialysate interferes with the measurement of creatinine resulting in its being overestimated in direct proportion to the glucose concentration. In our laboratory:
-([glucose (mmol/l)]0.47) Twenty-millilitre aliquots of fresh dialysate were taken under sterile conditions and sent to the microbiology laboratory for microscopy and culture. Samples were Gram stained and plated onto standard agar gels and incubated under aerobic and anaerobic conditions, as laid out in standard guidelines [18] . Dialysate leukocyte counts were estimated using a haemocytometer, and represented the total number of cells, including neutrophils (>90%), monocytes and mesothelial cells. Cell counts were made on three occasions for each peritonitis episode: on presentation, on day 3, and on day 12. In order to make a semiquantitative assessment of the peritoneal inflammation associated with recurrent or multiple infection episodes, the cumulative cell count from these multiple samplings was computed.
Statistical analysis
Low-molecular-weight solute transfer (D/P creat ) is normally distributed in the CAPD population [17] whereas UF and dialysate leukocyte counts are not. For D/P crcat , ANOVA and Students t test were used to compare multiple groups and paired data, whereas the Kruskall-Wallis and Wilcoxon test were used for non-parametric data respectively. Correlations were made using Spearman's coefficient for non-parametric data. Comparisons of actuarial technique survival between patients with isolated and multiple peritonitis were made using the Kaplan-Meier method, and the logrank test of significance.
Results
Peritoneal kinetics and peritonitis
The analysis of the effects of peritonitis on peritoneal kinetics was made using data obtained during the study period before and after infections from both group 1 S. J. Davies et al. and group 2. A total of 281 peritonitis episodes occurred during the study period; 87 of these were single isolated episodes, 58 double episodes due to recurrence, and 136 were part of 41 multiple recurrences or clusters of infections. Peritonitis was not evenly distributed amongst the patient population, with 60% of infections occurring in less than 10% of patients; 86 patients had no peritonitis.
Changes in D/P creat and UF occurring with single, recurrent, and multiple clusters of peritonitis are summarized in Table 1 . Single, isolated episodes were not associated with any significant change in either solute transfer or ultrafiltration volume. The median difference (95% confidence interval) in D/P creat was less than 3%, equivalent to the error associated with repeatability of the PET in the absence of peritonitis. In contrast, recurrent or multiple episodes were associated with significant increases in D/P cieat and reductions in UF volume. These changes tended to be greater when associated with more infections, although this was most marked for D/P creat after three episodes and for UF volume after four. Whilst in the majority of cases multiple infections caused increases in solute transfer and reductions in UF, in 4/28 recurrences and 11/41 clusters the opposite was seen. Although it is to be anticipated that biological data of this type is likely to vary in opposite ways at random, it is important to point out that the incremental changes in both D/P creat and UF were larger following multiple infections, regardless of their direction, as indicated to some extent by the median differences (and their 95% confidence limits) detailed in Table 1 . For example, in those circumstances where a reduction in D/P creat was observed following peritonitis, the median change following a single episode was -0.035 (« = 31), whereas following four episodes in was -0.09 (n = 6, P<0.05). This has important consequences for the interpretation of the net effect of peritonitis on solute transfer and ultrafiltration, as larger changes will tend to cancel each other out, causing them to be underestimated when mean values are considered. There were no obvious reasons, e.g. organism or duration of CAPD, to indicate why multiple infections caused opposite effects on peritoneal kinetics in some patients.
The effect of specific organisms on peritoneal kinetics is summarized in Table 2 . Culture-negative episodes caused virtually no change and coagulase negative staphylococci very small changes in solute transfer and ultrafiltration regardless of whether they caused single or multiple infections. Whilst pathogens such as S. aureus and Pseudomonas were associated with greater differences in peritoneal kinetics, this was only statistically significant for fungal peritonitis. However the post-infective D/P creat was significantly lower following culture-negative episodes when compared with all other groups, despite similar preinfection values. Establishing the true effect of different organisms on peritoneal kinetics is difficult when multiple infections are involved, as these were not always due to the same agent in each episode of peritonitis, and culturenegative episodes occasionally occurred. Multiple epis- odes were thus classified according to the predominant organism. It can also be seen from Table 2 that infection with these pathogens were also associated with higher cumulative dialysate leukocyte counts, suggesting that they caused a greater intensity of peritoneal inflammation. The relationship between the median observed dialysate leukocyte counts and infecting organisms is shown in more detail in Table 3 . When comparing all the peritonitis episodes, it is apparent that the initial cell count (day 1) is related to the infecting organism, with the lowest counts seen in culture-negative episodes, the highest with recognized pathogens. This pattern persists at day 3 and day 12, although there is resolution, albeit slower for S. aureus, Pseudomonas and other pathogens. The exception to this is fungal infections which do not resolve or were diagnosed late by comparison. The cumulative dialysate count resulting from multiple infections, again according to the predominant causative organism is also shown in Table 3 . Again the combination of several infections associated with known pathogens result in the highest cell counts. The overall correlation between the cumulative dialysate leukocyte count and incremental changes in D/P creat , Spearman's r = 0.41, P<0.01 (see Figure 1) , and UF r=0.31 .P=0.01, would suggest that it is not just the number of peritoneal infections but also the degree of associated peritoneal inflammation that determines the observed changes in peritoneal kinetics.
Longitudinal changes in peritoneal kinetics
Of the 166 patients in group 1 studied prospectively from the commencement of CAPD, actuarial survival at 60 months was 55% regardless of treatment modality. The technique survival curve and patient numbers at each timepoint are shown in Figure 2 , where the technical half-life for these patients was 38 months (technique failure was denned as either death or transfer to haemodialysis because of multiple peritonitis or clinical ultrafiltration failure). The analysis of longitudinal changes in solute transfer and ultrafiltration occurring with time spent on CAPD are shown in Figure 3 for the first 48 months of treatment, as numbers beyond this point did not permit statistical analysis. Following commencement of CAPD there was a sharp and highly significant increase in D/P creat (0.61 to 0.67, P< 0.001) during the first 6 months. Subsequently there was a further increase over the next 4 years, although this did not reach further statistical significance (P<0.05, ANOVA) until 42 and 48 months of treatment, when compared with values at 6 months. These changes in D/P creat were accompanied by a reduction in peritoneal ultrafiltration from 477 ml to 290 ml at 48 months by which time the trend was statistically significant (P<0.05). The correlation between D/P cr<:a t and body surface area, which was barely significant at the commencement of CAPD, (r = 0.18, P=0.05, «=166), increased over following 12 months: at 6 months r = 0.27, P=0.013, n = 91, and at 12 months r = 0.32, P=0.006, n = 80. Because of the profound effects of multiple peritonitis on peritoneal kinetics, which it could be argued were the principal cause of the longitudinal changes in peritoneal kinetics, the data was reanalysed. Patients in group 1 were divided on the basis of their peritonitis record into those who had either single/isolated/no episodes (group la) or those who had recurrent/multiple clusters of infections (group lb). During the first 18-24 months of treatment patients having multiple infections, group lb, had significantly higher D/P cr(:at (P = 0.0035), Figure 3 seen in all patients. Subsequently, over the next 3 years there was a gradual convergence in solute transfer and ultrafiltration. This was due in part to a steady increase in D/P creat and associated reduction in UF in those patients in group la, which was statistically significant by 42 months, but also to an accelerated drop out due to technique failure in group lb. Technique failure was significantly greater for group lb, with 25% on CAPD at 48 months compared with 48% in group la, (see Figure 2 , P = 0.04, log rank test). This difference was due to discontinuation of treatment rather than death, which was similar in both groups (P = 0.1). Months on CAPD 
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Discussion
The purpose of this study was to document in a prospective manner changes in peritoneal kinetics occurring with time spent on CAPD, with particular reference to those associated with peritonitis. The peritoneal equilibration test (PET) was used for this purpose for several reasons: firstly, we have previously described normal values, the relationship between solute transfer and ultrafiltration, and the diagnostic sensitivity of the test [17] . Several authors have established that the 4-h dialysate:plasma creatinine ratio is a good measure of low-molecular-weight solute transfer, comparing well with calculation of the mass transfer coefficient [19, 20] . Secondly, the relative simplicity of the test and its general adoption into clinical practice will allow nephrologists to compare the data presented here with their own clinical experience. Thirdly, although it would have been of considerable interest to examine other aspects of peritoneal kinetics, such as permeability to macromolecules and lymphatic absorption, this methodology is both time consuming and controversial [4, 21] , and would not have allowed the collection of such an extensive data set, which included 800 PETs.
There are, however, limitations in the PET which should be borne in mind when interpreting the information presented. Most importantly there are discrepancies between reproducibility of the two measurements made; whilst this is good for solute transfer (D/P creat ) the measure of ultrafiltration (UF) is open to a much greater error [17] . Furthermore whilst D/P creat is normally distributed, this is not the case for UF, which necessitates the use of less sensitive non-parametric statistical analysis. Changes in UF, therefore, which are probably of greater clinical relevance than solute transfer, are more difficult to demonstrate using this test.
This study has shown that peritonitis has important effects on peritoneal kinetics. The magnitude of these changes in solute transfer and ultrafiltration were proportional to the number of infections occurring within a cluster and the intensity of the associated peritoneal inflammation. If the causative organism was a recognized pathogen then the changes were greater than for culture-negative episodes or if due to the skin commensal Staphylococcus epidermidis, although mean changes in D/P creat and UF were not statistically significant.
Whilst there is general acceptance within the CAPD literature that peritonitis is harmful to the peritoneum, and a major cause of ultrafiltration failure, the actual data and documentation in support of this phenomenon is poor and controversial. Several studies have been unable to establish a link between peritonitis and changes in peritoneal function [22] [23] [24] [25] , and those which have [5, 6, 26, 27] , with the exception of that by Selgas et al. [7] , have either been in small selected groups of patients, or have inferred the changes in peritoneal kinetics from the requirements of hypertonic solutions or clinical outcome, rather than performing actual measurements. There are several potential reasons as to why this lack of clarity persists in the literature, which we have attempted to rectify in this study. By performing a prospective analysis of peritoneal kinetics, including a large unselected cohort of patients, and re-measuring them after every isolated, recurrence or cluster of peritonitis episodes we have been able to show that it is not the total number of infections, but the number occurring in close proximity that are associated with the greatest damage. Furthermore, whilst the majority of infection clusters cause increases in D/P creat and reductions in ultrafiltration, occasionally the opposite is the case. Previous studies have not generally taken these possibilities into account, and may as a result have failed to appreciate fully the effect of peritonitis on peritoneal function. The exception, as indicated above is the prospective analysis of peritoneal kinetics by Selgas et al. [7] , in which long-term increases in solute transfer and reductions in ultrafiltration were observed in those patients S. J. Davies et al. with greater accumulated number of days with peritoneal inflammation.
That peritonitis can cause injury and long-term changes in peritoneal function is not surprising when the morphological observations associated with infection are considered. Mesothelial injury with loss of microvilli, detachment from the basement membrane, and fibrin deposition, which persist even after removal and replacement of the peritoneal catheter, are well described [8, 28, 29] . These observations led us to examine the effect of not only the number of infections but also the intensity of the associated inflammation on subsequent alterations in peritoneal function. The summation of the dialysate leukocyte counts on days 1, 3 and 12 of cumulative infection episodes was used as a crude but simple index of peritoneal inflammation, which is obviously limited in its precision. The majority of these leukocytes are neutrophils that influx rapidly into the peritoneal cavity in response to infection, releasing reactive oxygen metabolites and enzymes such as elastase in proportion to the dialysate neutrophil count, which without functional inhibitors are able to initiate peritoneal damage [30, 31] . The finding in this study that there was a correlation between the changes in solute transfer, ultrafiltration, and the dialysate leukocyte counts provides further supportive evidence that intensity of inflammation as well as number of infectious episodes are important.
The data presented here have several important clinical implications, which tend to support the recommendations currently laid down in guidelines for the management of CAPD peritonitis [18] . It is encouraging to see that in general, single isolated episodes of infection do not have significant effects on peritoneal kinetics, particularly if the leukocyte count is less than 2000. Equally, culture-negative infections associated with less peritoneal inflammation cause less damage. However, as this study has also confirmed, peritonitis is not equally distributed amongst CAPD patients, but largely confined to a small subgroup who have recurrent infections resulting in a twofold increase in technical failure rate. The recommendation that where possible the peritoneal catheter is removed early in patients undergoing recurrences or clusters of infection, particularly if associated with severe inflammation or when due to recognized pathogens, is upheld.
Whilst the evidence that peritonitis can cause alterations in peritoneal kinetics is strong, concern remains that long-term changes related to the dialysis process itself can also cause gradual peritoneal damage. One of the aims of this study was to examine the longitudinal changes in peritoneal kinetics during the first 4 years of treatment, and subtract from this the effects of multiple peritonitis. The initial finding was a highly significant increase in D/P creat that occurred within the first 6 months of treatment. This was unexpected and contrary to the finding of the Dutch group who found an initially high solute transfer following commencement of CAPD [32] , which falls at 4 months to values similar to those obtained in this study. D/P creat is determined by the effective peritoneal surface area, Longitudinal peritoneal kinetics and peritonitis which is in turn influenced by the patients' size, the proportion of the peritoneal membrane in contact with dialysate, and the vascularity of the peritoneum. The first PET in this study was performed early, at the end of the training period, and it is tempting to suggest that this is before the whole peritoneum has made full contact with the dialysate. In keeping with this suggestion we have found that the correlation between D/P creat and body surface area, which is present on commencing treatment, increases at 6 and 12 months, and then subsequently declines. This does not explain the differences with the Dutch study, although it may be concluded from both studies that very early assessment of the PET may not be a reliable predictor of longer-term peritoneal function.
Following this early observation of peritoneal kinetics, there was a further gradual increase in solute transfer and reduction in ultrafiltration with time, although this did not reach statistical significance until 42 and 48 months. Similar values for peritoneal kinetics at given time-points were obtained from both the unselected cohort of new patients, group 1 and those selected by having been on treatment for at least 18 months, group 2, at the beginning of the study. Multiple episodes of peritonitis accelerated these trends considerably, but had little long-term influence due to the high drop-out rate in this group. Several of the patients in group lb had severe and multiple peritonitis from the commencement of CAPD, which almost certainly accounts for the significant differences in D/P creat and UF being present so early. Most significantly, those patients who had only isolated peritonitis episodes or none at all eventually caught up, with an increase in solute transfer and reduction in ultrafiltration. It would therefore appear that CAPD in the medium term is associated with progressive changes in peritoneal kinetics that cannot be wholly attributed to peritonitis. It is important, however, to sound a note of caution in the interpretation of these results. CAPD is a treatment associated with a high drop-out rate due to transplantation, patient death and technical failure. As such, relatively few patients who commence on CAPD are still on treatment 4 or more years later, and those who are have been subjected to heavy selection pressure. Whilst the technical failure rate of this cohort was relatively low in comparison with other studies, selection has still occurred and it cannot therefore be assumed that the trends observed in this study represent the natural history of the dialysed peritoneum. It should also be remembered that the direction of this selection pressure will, if anything, tend to selectively remove more patients with worse solute transfer and ultrafiltration problems, making the observations of this study all the more clinically relevant.
As with the published data on peritonitis and the peritoneum, longitudinal studies of peritoneal function are conflicting in their messages. Some studies with longitudinal data on small numbers of selected patients (less than 20) have failed to find significant changes with 4-5 years of treatment [24, 25] , whilst others have found a positive correlation between solute transfer 505 and time on treatment [23] , or that patients on dialysis for several years tend to be 'high average' transporters [22] . Several studies have identified time spent on CAPD as a risk factor for developing clinical ultrafiltration failure [4] [5] [6] . One study comparing patients treated for 5 years matched with those just commencing CAPD found significantly higher values for solute transport combined with lower ultrafiltration capacity following treatment [33] , and longitudinal data from the same group would suggest that this trend is already present at 24 months [32] . The present study and that by Selgas et al. [7] appear to tip the balance in favour of 4 or more years treatment with CAPD being associated with increased solute transfer and reduced ultrafiltration.
It is of interest to consider the possible causes and mechanism of these changes in peritoneal kinetics. The rise in solute transfer implies that there is an increase in the effective peritoneal surface area; as this is unlikely to represent a change in the size of the peritoneum it is probably due to an increase in the microvasculature of the peritoneum, whilst at the same time there is a reduction in permeability to macromolecules [33] . Ultrafiltration is inversely related to solute transfer, and we have previously described this relationship as it is characterized by the PET [17] . The longitudinal kinetic data in the present study showed an identical relationship for each time point beyond 6 months, indicating that the reductions in ultrafiltration observed were secondary to the changes in solute transfer and increased effective peritoneal surface area. As regards to the mechanism of this change, it is tempting to speculate that the continued low-grade activation of the peritoneal immune system that has been described [10, 12, 14] is a potential trigger for longterm changes in peritoneal vascularity. This study would suggest that peritonitis free, biocompatible dialysis remains an important goal for the long-term use of peritoneum as a dialytic membrane.
